The Impact of Malignant Disease on Facial Nerve Function After Parotidectomy
- 1 August 2003
- journal article
- Published by Wiley in The Laryngoscope
- Vol. 113 (8) , 1299-1303
- https://doi.org/10.1097/00005537-200308000-00006
Abstract
Studies of immediate postoperative facial nerve function following parotidectomy focus on benign disease. The purpose of the study was to compare facial nerve function with regard to benign or malignant disease in patients undergoing superficial parotidectomy. Retrospective cohort study of consecutive patients undergoing parotidectomy between 1995 to 2002. House-Brackmann (HB) grade was recorded or assigned at the first postoperative visit. For patients with HB grade of III or greater, final resolution of facial nerve function was recorded. A chi2 analysis for independence was conducted between patients with HB grade of II or less and those with HB grade of III or greater and final pathological finding (benign vs. malignant disease). Mean and median times to resolution were determined for patients with HB grade of III or greater. Times to resolution for benign and malignant disease for those with HB grade of III or greater were compared (Kaplan-Meier method). Sixty-seven patients with benign disease and 52 with malignant disease were included. Ninety-four percent of patients with benign disease had HB grade of II or less at first postoperative visit (mean period, 11.6 d) compared with 76.9% of patients with malignant disease (mean period, 12.4 d). A chi2 analysis found this difference significant (chi2 = 7.36, P =.0067). Time to resolution for HB grade of III or greater was 253.8 days (+/-168.2 d) with median time of 229.5 days for benign disease and 182.4 days (+/-134.6 d) with median time of 138 days for malignant disease. Kaplan-Meier comparison found no significant differences in time to final resolution (P =.83). Three patients in the group with malignant disease had unresolved dysfunction (one patient for >2 y). Patients with benign disease have a greater chance of having HB grade of II or less immediately following surgery; however, whether the disease is benign or malignant, long-term final facial nerve function is the same.Keywords
This publication has 11 references indexed in Scilit:
- Parotid neoplasms: diagnosis, treatment, and intraparotid facial nerve anatomyThe Journal of Laryngology & Otology, 2002
- Parotid gland surgery: a retrospective review of 108 casesThe Journal of Laryngology & Otology, 2002
- Facial nerve function after partial superficial parotidectomy: An 11‐year review (1987‐1997)Otolaryngology -- Head and Neck Surgery, 1999
- Facial Nerve Function After ParotidectomyJAMA Otolaryngology–Head & Neck Surgery, 1997
- Long-term follow-up of over 1000 patients with salivary gland tumours treated in a single centreBritish Journal of Surgery, 1996
- Total conservative parotidectomy for primary benign pleomorphic adenoma of the parotid gland: A 25‐year experience with 229 patientsThe Laryngoscope, 1994
- EVALUATION OF 242 CONSECUTIVE PAROTIDECTOMIES PERFORMED FOR BENIGN AND MALIGNANT DISEASEAnz Journal of Surgery, 1993
- Facial nerve morbidity following parotid surgery for benign disease: The cleveland clinic foundation experienceThe Laryngoscope, 1993
- The Usefulness of Partial Parotidectomy for Benign Parotid Gland Tumors A retrospective study of 306 casesActa Oto-Laryngologica, 1993
- Benign parotid tumors: A 24‐year experienceJournal of Surgical Oncology, 1991